Oncology Practice Management Issues

November 2016, Vol 6, No 11

FDA News – November 2016

FDA Approvals, News & Updates

In This Article Tecentriq First PD-L1 Approved for Metastatic NSCLC with EGFR or ALK mutations Lartruvo First Therapy Approved for Soft-Tissue Sarcoma in 40 Years Keytruda Receives New FDA Indication for First-Line Treatment of Metastatic NSCLC Use of Screening Tests [ Read More ]